Brock T G, McNish R W, Peters-Golden M
Department of Internal Medicine, University of MIchigan Medical Center, Ann Arbor 48109-0652, USA.
J Biol Chem. 1995 Sep 15;270(37):21652-8. doi: 10.1074/jbc.270.37.21652.
Leukotriene (LT) synthesis involves the translocation of enzymatically active 5-lipoxygenase (5-LO) from a soluble site to a bound site, where it interacts with 5-lipoxygenase-activating protein (FLAP). In human polymorphonuclear leukocytes (PMNs), 5-LO moves from the cytosol to the nuclear envelope (NE) to interact with FLAP. However, 5-LO has recently been found within the nucleus, as well as the cytosol, of rat basophilic leukemia (RBL) cells and alveolar macrophages (AMs). To assess whether nuclear 5-LO can contribute to LT synthesis in these cells, we investigated whether this enzyme pool 1) translocates upon cell activation, 2) colocalizes with FLAP, and 3) is enzymatically active. By cell fractionation followed by immunoblotting, both cytosolic and nuclear soluble 5-LO decreased dramatically in RBL cells following activation with the calcium ionophore A23187. Concurrently, 5-LO increased in the pelletable nuclear pool, where FLAP was also detected. The loss of both cytosolic and nuclear soluble 5-LO, with concomitant increase exclusively at the NE, as well as co-localization with FLAP, were confirmed by indirect immunofluorescent and confocal microscopy. In AMs, the nuclear soluble pool of 5-LO moved to the NE, where FLAP was also found; however, the cytosolic 5-LO pool did not translocate. Application of these methods to PMNs confirmed that cytosolic 5-LO moved to the nuclear envelope and co-localized with FLAP. By cell-free assay, nuclear soluble proteins from both RBL cells and AMs, but not PMNs, were able to generate 5-LO products from arachidonate, and this was inhibited by the direct 5-LO inhibitor zileuton. Cytosolic proteins from all cell types also showed cell-free 5-LO activity. These results demonstrate three distinct patterns of 5-LO translocation that are specific for each cell type: translocation of only a cytosolic pool in PMNs, of only a nuclear pool in AMs, and of both cytosolic and nuclear pools in RBL cells. By virtue of its enzymatic activity and ability to translocate, nuclear 5-LO has the potential to contribute to LT synthesis in RBL cells and AMs. Finally, these results provide a foundation for considering the individual functions of discrete pools of 5-LO in future studies.
白三烯(LT)的合成涉及具有酶活性的5-脂氧合酶(5-LO)从可溶性位点转移至结合位点,在该位点它与5-脂氧合酶激活蛋白(FLAP)相互作用。在人类多形核白细胞(PMN)中,5-LO从胞质溶胶转移至核膜(NE)以与FLAP相互作用。然而,最近在大鼠嗜碱性白血病(RBL)细胞和肺泡巨噬细胞(AM)的细胞核以及胞质溶胶中均发现了5-LO。为了评估细胞核中的5-LO是否有助于这些细胞中LT的合成,我们研究了该酶库是否:1)在细胞激活时发生转移;2)与FLAP共定位;3)具有酶活性。通过细胞分级分离后进行免疫印迹分析,在用钙离子载体A23187激活后,RBL细胞中的胞质溶胶和细胞核可溶性5-LO均显著减少。同时,可沉淀的细胞核库中的5-LO增加,在该细胞核库中也检测到了FLAP。通过间接免疫荧光和共聚焦显微镜证实了胞质溶胶和细胞核可溶性5-LO均减少,且仅在核膜处同时增加,以及与FLAP共定位。在AM中,细胞核可溶性5-LO库转移至核膜,在核膜处也发现了FLAP;然而,胞质溶胶中的5-LO库未发生转移。将这些方法应用于PMN证实胞质溶胶中的5-LO转移至核膜并与FLAP共定位。通过无细胞分析,来自RBL细胞和AM的细胞核可溶性蛋白,但不包括PMN的,能够从花生四烯酸生成5-LO产物,并且这被直接的5-LO抑制剂齐留通所抑制。来自所有细胞类型的胞质溶胶蛋白也显示出无细胞5-LO活性。这些结果表明5-LO转移存在三种不同模式,每种细胞类型都具有特异性:PMN中仅胞质溶胶库发生转移,AM中仅细胞核库发生转移,RBL细胞中胞质溶胶库和细胞核库均发生转移。由于其酶活性和转移能力,细胞核中的5-LO有潜力促进RBL细胞和AM中LT的合成。最后,这些结果为在未来研究中考虑5-LO离散库的个体功能提供了基础。